Business
Abivax Biotech Company's Acquisition Delayed
Despite a surge in biotech mergers and acquisitions, French drugmaker Abivax has not yet been acquired. The company is facing delays that may be due to internal issues or market conditions.
Coverage timeline — 1 article
STAT News
Biotech M&A activity is off the charts, yet the French drugmaker Abivax hasn't been picked up yet. There may be some explanations.
2026-09-03 10:30 UTC